Management Consulting

Corporate Strategy Planning

Aligning your business with your goals

When you partner with Alira Health, we’ll deliver full spectrum support from our team of global specialists. You’ll benefit from a comprehensive industry evaluation, complete with local market condition assessment. Together, we’ll review your company operations and create a short- and long-term plan to align them with your mission, values, goals and vision.

Creating a tailored, focused plan for the future

The complex nature of the healthcare and life sciences landscape demands intentional long-range planning. The attrition and costs of the industry favor companies who dedicate resources to creating strategies that provide detailed operational activities to meet their long-term goals.
That's why, as your partner, Alira Health creates a plan tailored for your business with four objectives in mind:
  • Formalizing your business vision and long-term ambition
  • Outline the full spectrum of scenarios that may take place
  • Define a set of assumptions and review the impact of changes
  • Align employees around the company’s long-term ambition, defining operational activities and KPIs to support the goals

Why choose Alira Health?

As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:

  • Regulatory strategy
  • Regulatory intelligence
  • Regulatory operations
  • Clinical
  • Market access
  • Click here to see how we delivered a recent growth opportunity assessment for a leading pharmaceutical company

Connect with a Winning Team

See why Alira Health was named one of the world’s best management consulting firms by Forbes.

Related news

Publications September 19, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
CDMO Pharma
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
Blog July 24, 2023
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Biotech Drug Development Pharma
Publications July 11, 2023
Mid-size Pharma Accelerates Early Clinical Trial Engagement of Patients with A Rare Neurological Disease
A mid-size pharma company sought an experienced advisor who could help them engage patients for an open-label extension clinical study in a rare neurological disease.
Clinical Trials Patient Engagement Pharma Rare Disease
Publications July 10, 2023
The EU Pharmaceutical Package: Regulatory Protection Changes
Our regulatory experts present a more detailed analysis of the proposed changes introduced to Regulatory Data Protection (RDP).
EU Pharma Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.